Health care stocks were lower Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding about 0.4%.
The iShares Biotechnology ETF (IBB) fell 1%.
In corporate news, Spingworks Therapeutics (SWTX) shares jumped over 36%. The company is in advanced talks to be acquired by Merck KGaA, Reuters reported.
Axsome Therapeutics (AXSM) shares rose 21% after the firm said it agreed to a settlement deal with Teva (TEVA) to resolve patent litigation over its Auvelity product. Teva was down 0.8%.
Pliant Therapeutics (PLRX) shares fell 59% after the firm paused enrollment and dosing in a phase 2b trial of bexotegrast in idiopathic pulmonary fibrosis patients. Several analysts downgraded the stock following the announcement.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。